Bedömning av GORE® SYNECOR biomaterial i fokuserade patientpopulationer och långtidsapplikationer (SYN 20-01)
The SYN 20-01 Study is a non-interventional, prospective, multicenter, multicohort, international, post-market clinical investigation looking into the assessment of GORE® SYNECOR Biomaterial in focused patient populations and in long-term application.
Patients with ventral / incisional hernia amenable to hernia mesh repair will be enrolled into two cohorts (US and EU cohort) and followed-up over the period of 60 months.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Beräknad)
Kontakter och platser
Studieorter
-
-
Georgia
-
Atlanta, Georgia, Förenta staterna, 30342
- Emory Saint Joseph's Hospital
-
-
Massachusetts
-
Boston, Massachusetts, Förenta staterna, 02111
- Tufts Medical Center
-
-
Michigan
-
Grand Rapids, Michigan, Förenta staterna, 49506
- Corewell Health
-
-
New Mexico
-
Albuquerque, New Mexico, Förenta staterna, 87109
- Lovelace Women's Hospital
-
-
New York
-
Stony Brook, New York, Förenta staterna, 11794
- Stony Brook University Hospital
-
-
North Carolina
-
Wilmington, North Carolina, Förenta staterna, 28401
- Novant Health New Hanover Regional Medical Center
-
-
South Carolina
-
Greenville, South Carolina, Förenta staterna, 29605
- Prisma Health Greenville Memorial Hospital
-
-
Virginia
-
Mechanicsville, Virginia, Förenta staterna, 23116
- Bon Secours Memorial Regional Medical Center
-
-
-
-
-
Baggiovara, Italien, 41126
- Ospedale Civile di Baggiovara
-
Naples, Italien, 80131
- Vincenzo Monaldi Hospital
-
Roma, Italien, 00189
- Sapienza Università di Roma
-
-
-
-
-
Seville, Spanien, 41009
- University Hospital Virgen Macarena - Department of General And Digestive Surgery
-
Seville, Spanien, 41013
- Hospital Quirón Salud-Sagrado Corazón
-
-
-
-
-
Birmingham, Storbritannien, B15 2GW
- University Hospitals Birmingham NHS Foundation Trust - Queen Elizabeth Hospital Birmingham
-
Walsall, Storbritannien, WS2 9PS
- Walsall Manor Hospital
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
The SYN 20-01 study population will consist of patients who present with ventral/incisional hernia disease requiring treatment per the evaluating physician. Eligible study subjects need to be amenable to treatment with a permanent synthetic mesh as suggested by the inclusion and exclusion criteria for each study cohort.
Beskrivning
Key Inclusion Criteria - IP Cohort:
- De-Novo ventral/incisional hernia amenable to repair with GORE® SYNECOR IP Biomaterial
- Clean wound (CDC Wound Class I)
- mVHWG Grade 1 or 2 (modified Ventral Hernia Working Group)
Key Exclusion Criteria - IP Cohort:
- Wound is either clean-contaminated, contaminated or dirty-infected
Key Inclusion Criteria - PRE Cohort:
- De-novo ventral/incisional hernia, with subject anatomy and surgical plan amenable to open surgical repair or minimally invasive surgery with the GORE® SYNECOR PRE Biomaterial placed in a sublay fashion within the preperitoneal space
- Clean wound (CDC Wound Class I)
- mVHWG Grade 1 or 2 (modified Ventral Hernia Working Group)
Key Exclusion Criteria - PRE Cohort:
- Wound is either clean-contaminated, contaminated or dirty-infected
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: COHORT
- Tidsperspektiv: PROSPECTIVE
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
|---|---|
|
SYNECOR IP Device
Hernia mesh repair with GORE® SYNECOR Intraperitoneal Biomaterial |
Hernia repair with GORE® SYNECOR Biomaterial; technical approach laparoscopic, robotic or open surgical / minimally invasive surgery |
|
SYNECOR PRE Device
Hernia mesh repair with GORE® SYNECOR Preperitoneal Biomaterial |
Hernia repair with GORE® SYNECOR Biomaterial; technical approach laparoscopic, robotic or open surgical / minimally invasive surgery |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Hernia Recurrence
Tidsram: 24 Months
|
Hernia Recurrence Treated Location |
24 Months
|
|
Hernia Recurrence
Tidsram: 60 Months
|
Hernia Recurrence Treated Location |
60 Months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Hospital Re-Admission
Tidsram: 60 Months
|
Device or procedural-related |
60 Months
|
|
Thirty-Day Mortality
Tidsram: 30 Day
|
Mortality of all causes |
30 Day
|
|
SSO within 24 months post-procedure
Tidsram: 24 Months
|
Surgical Site Occurrence (SSO) |
24 Months
|
|
SSI (Surgical Site Infection)
Tidsram: 60 Months
|
Surgical Site Infection (SSI) |
60 Months
|
|
Freedom from mesh-involved events
Tidsram: 60 Months
|
Freedom from mesh-involved events |
60 Months
|
|
Major Seroma (clinically confirmed)
Tidsram: 60 Months
|
Major Seroma as clinically assessed (physiological parameters) and defined as seroma requiring treatment in the presence of infection, recurrence, mesh rejection or the need to be punctured/aspirated will be described without specific hypothesis or formal goal. Number of subjects with reported major seroma will be described as clinically confirmed by the investigator. |
60 Months
|
|
Change in Quality of Life (QoL) - SF 36 Questionnaire
Tidsram: 60 Months
|
SF 36 Questionnaire (36-Item Short Form Survey Instrument; possible score ranges from 0 to 100 points. 0 points represent the greatest possible limitation of health, while 100 points represent the absence of health restrictions) |
60 Months
|
|
Change in Quality of Life (QoL) - Carolinas Comfort Scale (CCS)
Tidsram: 60 Months
|
Carolinas Comfort Scale (CCS); CCS was designed that a lower score indicates a favorable health status; the total score is based on a scale of 0 - 115) |
60 Months
|
|
Ventral Hernia Recurrence Inventory sensitivity / specificity within 60 Month Follow-Up
Tidsram: 60 Months
|
VHRI Survey (Ventral Hernia Recurrence Inventory) |
60 Months
|
|
Adverse Events by Clavien Dindo Classification
Tidsram: 60 Months
|
Adverse Events by Clavien Dindo Classification |
60 Months
|
|
Surgical Site Occurrences (SSOPI) requiring Procedural Intervention
Tidsram: 24 Months
|
Surgical Site Occurrences (SSOPI) requiring Procedural Intervention |
24 Months
|
|
Surgical Site Occurrences (SSOPI) requiring Procedural Intervention
Tidsram: 60 Months
|
Surgical Site Occurrences (SSOPI) requiring Procedural Intervention |
60 Months
|
Samarbetspartners och utredare
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- SYN 20-01
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
produkt tillverkad i och exporterad från U.S.A.
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .